Latest filing published 16 Dec 2024 for Medicamen Biotech Limited, €2,136. Read the official filing
Geetika Madan is a declared insider of Medicamen Biotech Limited, with filings sourced from SEBI (PIT + SAST). Over a trading history stretching from 28 February 2024 to 12 December 2024, the count stands at 12 filings.
No open-market purchase appears, only 9 sales worth €220k.
On 16 December 2024 came the latest disclosure, a transaction for €15k in Medicamen Biotech Limited. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 4 days. That lag is the time during which only the insider knows about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations